Erich Kraus

Title: Erich Kraus: Innovator in Pharmaceutical Chemistry

Introduction

Erich Kraus is a notable inventor based in Essen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug synthesis. His work has implications for the treatment of various medical conditions, showcasing the importance of research and development in the pharmaceutical industry.

Latest Patents

Kraus holds a patent for a process titled "Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino] acetic acid." This patent discloses methods and processes for preparing vadadustat and its pharmaceutically acceptable salts. The invention also includes intermediates useful for the synthesis of vadadustat, highlighting Kraus's expertise in creating effective pharmaceutical compounds.

Career Highlights

Erich Kraus is currently employed at Akebia Therapeutics, Inc., where he continues to advance his research in drug development. His work at Akebia Therapeutics has positioned him as a key player in the pharmaceutical industry, contributing to the company's mission of developing innovative therapies for patients.

Collaborations

Kraus has collaborated with notable colleagues, including Boris Gorin and Christopher M. Lanthier. These collaborations have fostered a productive environment for innovation and have led to advancements in their shared field of expertise.

Conclusion

Erich Kraus exemplifies the spirit of innovation in pharmaceutical chemistry through his patent and contributions to Akebia Therapeutics. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in the medical field.